| Bioactivity | LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1]. | ||||||
| Name | LCMV gp33-41 TFA | ||||||
| Sequence | Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Met | ||||||
| Shortening | KAVYNFATM | ||||||
| Formula | C50H74N11F3015S | ||||||
| Molar Mass | 1158.24 | ||||||
| Appearance | Solid | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Gairin JE, et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol. 1995 Apr;69(4):2297-305. |
LCMV gp33-41 TFA
CAS: F: C50H74N11F3015S W: 1158.24
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restrict
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.